This week Gilead Sciences slashed its 2020 revenue forecast, citing lower than expected demand for the COVID-19 drug Remdesivir. The company also said it was finding it difficult to predict sales of the drug, which is the only treatment in the U.S. that has been approved for patients who are hospitalized with COVID-19. The drug … Continue reading “Sales for Covid-19 Drug Remdesivir Fall Short Prompting Gilead to Cut 2020 Sales Outlook”
Biotech & Pharma
Biotech & Pharma
Vertex Shares Drop After Company Stops Testing on Protein Deficiency Treatment
Shares of pharmaceutical company Vertex Pharmaceuticals were falling this week after the company announced that…
October 16, 2020
Biotech & Pharma
Eli Lilly Shares Soar After Company Requests FDA Clearance for Antibody Drug
Shares of Eli Lilly were on the rise on Wednesday after Wall Street learned that…
October 8, 2020
Biotech & Pharma
Bristol Myers to Acquire MyoKardia for $13 Billion
Wall Street learned this week that Bristol Myers is expanding its heart drug business with…
October 6, 2020
Biotech & Pharma
Illumina Says it Will Purchase Bezos-Backed Grail for $8B
Illumina, a global leader in genomics, announced this week that it will be acquiring the…
September 22, 2020
Biotech & Pharma
Gilead to Buy Cancer-drug Company Immunomedics for $21B
Over the weekend Gilead announced that it has agreed to purchase cancer-drug company Immunomedics for…
September 15, 2020
Biotech & Pharma
Trillium Therapeutics Shares Explode on Pfizer Investment
Shares of Trillium Therapeutics were skyrocketing over 40% on a $25 million Pfizer investment this…
September 11, 2020
Biotech & Pharma
Sarepta Therapeutics Shares Crumble After Regulators Request More Work to Be Done
Sarepta Therapeutics saw its share price dip on Thursday after regulators requested more work be…
September 11, 2020
Biotech & Pharma
AbbVie Inc. Signs $2.9 Billion Deal with China’s I-Mab
Drugmaker AbbVie Inc. has inked a deal with Chinese drug developer I-Mab to collaborate on…
September 8, 2020
Biotech & Pharma
AstraZeneca Pauses Late Stage COVID-19 Vaccine Trial
Wall Street learned on Tuesday that multinational pharmaceutical giant AstraZeneca has paused a late-stage trial…
September 8, 2020
Biotech & Pharma
Inovio Pharmaceuticals Falls on Short Seller’s Comments About Coronavirus Hype
Inovio Pharmaceuticals shares were falling on Wednesday after short seller Muddy Waters revealed that it…
September 3, 2020
Biotech & Pharma
Nestlé Health Science to Acquire Aimmune Therapeutics to Create Global Leader in Food Allergy Prevention
Biopharmaceutical giant Nestlé announced that it will be acquiring Aimmune Therapeutics to create a global…
August 31, 2020
Biotech & Pharma
Moderna Reveals its Coronavirus Vaccine Has had Promising Results
Biotech company Moderna has revealed this week that its coronavirus vaccine has shown promising results…
August 27, 2020
Biotech & Pharma
Abbott Laboratories Scores U.S. Authorization for a Rapid Covid-19 Antigen
On Wednesday medical devices and healthcare company Abbott Laboratories announced that it has won U.S.…
August 27, 2020